Skip to main content
. 2016 Oct 12;2016(10):CD002042. doi: 10.1002/14651858.CD002042.pub4

ISRCTN26088319.

Methods Randomised clinical trial
Participants Participants with myelodysplastic syndrome, transfusion dependent, and life expectancy > 6 months
Interventions Liberal: to maintain haemoglobin concentration
Restrictive: to maintain a haemoglobin level between 8.5 g/dL and 10 g/dL
Outcomes Percentage of compliance of pretransfusion haemoglobin levels and achievement of at least 2 g/dL difference between liberal and restrictive transfusion
Notes